ArticleCurrent pharmaceutical design2024

Celastrol Elicits Antitumor Effects through Inducing Immunogenic Cell Death and Downregulating PD-L1 in ccRCC.

Hong-Fang Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.